Skip to main content

Table 5 Disease versus patient-oriented outcomes

From: Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review

Disease-oriented outcomes

Patient-oriented outcomes

Total cholesterol, LDL, HDL

Rate of hospitalization


Length of stay

Haematocrit, Tsat, ferritin, haemoglobin

Health-related quality of life


Medication-related knowledge

Phosphorus, calcium-phosphorus product

Renal quality of life

Drug dosages (e.g., EPO dosage or ferrous dosage)

Patient satisfaction survey